AbCellera’s New Ownership Shift: Stability or Hurdle to Innovation?
Explore how AbCellera’s cutting‑edge antibody tech and 2026 share‑donation reveal a unique ownership dynamic that could shape its future innovation and investor appeal.
3 minutes to read
